Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2010: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
|
Research Abstract |
Allergen-specific immunotherapy (SIT) is currently used for several allergic disorders, and we have investigated the induction of IL-10-producing regulatory T cells (Tr1) and IL-10 producing monocytes by SIT. CD4 T cells and monocytes from SIT group produced high levels of IL-10, suggesting that the induction of IL-10 is essential for T cell tolerance. The low productivity of IL-10 may be closely related with sensitivity to multiple allergens, and resistance to allergic diseases.
|